The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick pickspolarean Regulatory News (POLX)

Share Price Information for polarean (POLX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 3.70
Bid: 3.60
Ask: 3.80
Change: 0.05 (1.37%)
Spread: 0.20 (5.556%)
Open: 3.65
High: 3.70
Low: 3.68
Prev. Close: 3.65
POLX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

2 Apr 2020 14:12

RNS Number : 6183I
Polarean Imaging PLC
02 April 2020
 

TR-1: Standard form for notification of major holdings

 

NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible)i

1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attachedii:

POLAREAN IMAGING PLC

1b. Please indicate if the issuer is a non-UK issuer (please mark with an "X" if appropriate)

Non-UK issuer

2. Reason for the notification (please mark the appropriate box or boxes with an "X")

An acquisition or disposal of voting rights

X

An acquisition or disposal of financial instruments

An event changing the breakdown of voting rights

 

Other (please specify)iii:

3. Details of person subject to the notification obligationiv

Name

Amati AIM VCT plc

City and country of registered office (if applicable)

London, England

4. Full name of shareholder(s) (if different from 3.)v

Name

City and country of registered office (if applicable)

5. Date on which the threshold was crossed or reachedvi:

02/04/2020

6. Date on which issuer notified (DD/MM/YYYY):

02/04/2020

7. Total positions of person(s) subject to the notification obligation

% of voting rights attached to shares (total of 8. A)

% of voting rights through financial instruments(total of 8.B 1 + 8.B 2)

Total of both in % (8.A + 8.B)

Total number of voting rights of issuervii

Resulting situation on the date on which threshold was crossed or reached

14.61%

14.61%

161,295,607

Position of previous notification (if

applicable)

10.89%

10.89%

 

8. Notified details of the resulting situation on the date on which the threshold was crossed or reachedviii

A: Voting rights attached to shares

Class/type ofshares

ISIN code (if possible)

Number of voting rightsix

% of voting rights

Direct

(Art 9 of Directive 2004/109/EC) (DTR5.1)

Indirect

(Art 10 of Directive 2004/109/EC) (DTR5.2.1)

Direct

(Art 9 of Directive 2004/109/EC) (DTR5.1)

Indirect

(Art 10 of Directive 2004/109/EC) (DTR5.2.1)

GB00BF3DT583

23,571,429

14.61%

SUBTOTAL 8. A

23,571,429

14.61%

 

 

B 1: Financial Instruments according to Art. 13(1)(a) of Directive 2004/109/EC (DTR5.3.1.1 (a))

Type of financial instrument

Expirationdatex

Exercise/Conversion Periodxi

Number of voting rights that may be acquired if the instrument is

exercised/converted.

% of voting rights

SUBTOTAL 8. B 1

 

 

B 2: Financial Instruments with similar economic effect according to Art. 13(1)(b) of Directive 2004/109/EC (DTR5.3.1.1 (b))

Type of financial instrument

Expirationdatex

Exercise/Conversion Period xi

Physical or cash

settlementxii

Number of voting rights

% of voting rights

SUBTOTAL 8.B.2

 

 

 

 

9. Information in relation to the person subject to the notification obligation (please mark the

applicable box with an "X")

Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuerxiii

X

Full chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held starting with the ultimate controlling natural person or legal entityxiv (please add additional rows as necessary)

Namexv

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

10. In case of proxy voting, please identify:

Name of the proxy holder

The number and % of voting rights held

The date until which the voting rights will be held

11. Additional informationxvi

 

Place of completion

Edinburgh, Scotland

Date of completion

02/04/2020

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
HOLUUAORRRUSRAR
Date   Source Headline
28th Dec 20229:05 amRNSSecond Price Monitoring Extn
28th Dec 20229:00 amRNSPrice Monitoring Extension
28th Dec 20227:00 amRNSFDA Approves XENOVIEW™ (Xe 129 hyperpolarized)
3rd Oct 202211:05 amRNSSecond Price Monitoring Extn
3rd Oct 202211:00 amRNSPrice Monitoring Extension
30th Sep 20227:00 amRNSUpdate on New Drug Application
22nd Sep 20222:05 pmRNSSecond Price Monitoring Extn
22nd Sep 20222:00 pmRNSPrice Monitoring Extension
22nd Sep 202211:06 amRNSSecond Price Monitoring Extn
22nd Sep 202211:00 amRNSPrice Monitoring Extension
22nd Sep 20229:05 amRNSSecond Price Monitoring Extn
22nd Sep 20229:00 amRNSPrice Monitoring Extension
22nd Sep 20227:04 amRNSUpdate on New Drug Application
31st Aug 20227:00 amRNSHalf-year Report
26th Aug 20227:00 amRNSDirectorate appointment
4th Aug 20224:40 pmRNSSecond Price Monitoring Extn
4th Aug 20224:35 pmRNSPrice Monitoring Extension
28th Jul 20227:00 amRNSTotal voting rights and block listing return
8th Jul 20227:00 amRNSSystem delivery
29th Jun 20224:35 pmRNSResult of AGM
18th May 20227:00 amRNSFinal Results
11th May 20227:00 amRNSNotice of Results
11th May 20227:00 amRNSOxford research collaboration in long COVID
5th May 20227:00 amRNSDirectorate Change
29th Apr 20227:00 amRNSTotal Voting Rights
25th Apr 20227:00 amRNSNew system order
20th Apr 20227:00 amRNSNew Drug Application Resubmission update
14th Apr 20227:00 amRNSAppointment of Non-Executive Director
8th Apr 20227:00 amRNSExercise of Options and Total Voting Rights
31st Mar 20222:05 pmRNSSecond Price Monitoring Extn
31st Mar 20222:00 pmRNSPrice Monitoring Extension
31st Mar 202211:06 amRNSSecond Price Monitoring Extn
31st Mar 202211:00 amRNSPrice Monitoring Extension
31st Mar 20229:00 amRNSPrice Monitoring Extension
31st Mar 20227:00 amRNSNew Drug Application Resubmission
25th Feb 20227:00 amRNSTotal Voting Rights
14th Feb 20227:00 amRNSNew system order
28th Jan 20227:01 amRNSBlock Listing Return
28th Jan 20227:00 amRNSTotal Voting Rights
4th Jan 20227:00 amRNSTotal Voting Rights
30th Nov 20217:00 amRNSTotal Voting Rights
26th Oct 20214:41 pmRNSSecond Price Monitoring Extn
26th Oct 20214:36 pmRNSPrice Monitoring Extension
26th Oct 20212:05 pmRNSSecond Price Monitoring Extn
26th Oct 20212:00 pmRNSPrice Monitoring Extension
12th Oct 20214:41 pmRNSSecond Price Monitoring Extn
12th Oct 20214:35 pmRNSPrice Monitoring Extension
12th Oct 20212:06 pmRNSSecond Price Monitoring Extn
12th Oct 20212:00 pmRNSPrice Monitoring Extension
11th Oct 20219:05 amRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.